Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.

BMC Infect Dis · 2010 · PMC2845586 · PMID 20298555

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

a significant trendp < 0.01actually significant

A significant trend toward a higher Etest MIC result was observed among these results for the two compounds (p < 0.01).

also in 4,888 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.